retatrutide phase 2 trial obesity nejm 2023 VisualAbstract: reduces body weight by 17.5% in patients with Retatrutide: The Three Receptors It

Semaglutide users who alternate between constipation and diarrhea, a surprisingly common pattern, may find LGG helpful for stabilizing bowel function in either direction

For anyone following retatrutide or taking part in a trial, that means one place for a shot log, body diagram site tracking, side effect notes, food logging, the medication graph, and the long weight trend

They do not need to demonstrate safety in controlled studies

It is provided solely for laboratory research purposes and must not be used for diagnostic or therapeutic purposes, in food, cosmetics, or any medical applications

Specification and emulation of the reference trial including our expansion studies are stated in the Supplementary Information, following the TrAnsparent ReportinG of observational studies Emulating a Target trial (TARGET) guideline (Supplementary Tables 2729) 42

It also helps to separate two different questions people tend to blur together